Introduction
Alteration of the TP53 tumor suppressor gene is the most common genetic defect in human tumors (Hainaut and Hollstein, 2000) . Wild-type p53 plays a key role in the maintenance of genomic stability and is required for the apoptotic response of cells to radioand chemotherapy. The most important biochemical function of p53 is activation of the expression of genes involved in control of the cell cycle, apoptosis, cellular dierentiation and DNA repair (Oren, 1999; Oren and Rotter, 1999) . Transcriptional targets of p53 include, among others, cell cycle regulatory genes such as p21/ WAF1, an inhibitor of cyclin-dependent kinases (el Deiry et al., 1993) , pro-apoptotic genes such as BAX, a regulator of mitochondrial permeability (Miyashita et al., 1994) and PIG3, a quinone oxido-reductase homolog (Polyak et al., 1997) .
The ability to bind DNA and transactivate genes is altered in p53 mutant proteins associated with cancer. The majority of the TP53 alterations are missense mutations localized in the DNA-binding domain, abolishing the transcriptional activity of the protein (Hainaut and Hollstein, 2000) . Several classes of mutant proteins have been identi®ed (Cho et al., 1994) . Class I mutants have lost crucial protein-DNA contacts by mutation of residues directly involved in DNA binding. Class II mutants have acquired an abnormal conformation due to mutations of residues important for the maintenance of protein structure. A third class comprises mutants which retain a limited capacity to bind to DNA. This class includes temperature-sensitive mutants, which undergo partial or complete recovery of wild-type conformation at certain temperatures (Di Como and Prives, 1998; Rolley et al., 1995) and other mutants which have only partial loss of activity and retain the capacity to transactivate high-anity target genes such as p21/ WAF1 (Rowan et al., 1996; Ryan and Vousden, 1998; Flaman et al., 1998) . Such mutants can be de®ned as¯e xible mutants'. Many cytotoxic drugs used in cancer treatment require the presence of wild-type p53 protein to induce cell death. Mutations in TP53 have been found to be associated with drug resistance in vitro as well as in animal models (Lowe et al., 1993 (Lowe et al., , 1994 . Re-expression of functional p53 in cells in which the endogenous TP53 gene is inactivated restores a non-tumorigenic phenotype by suppressing tumor growth and inducing apoptosis (Lang et al., 1998; Roth et al., 1996) . Pharmacological modulation of mutant p53 to restore the wild-type conformation may therefore represent a mechanism to reactivate p53 function and consequently improve the response to radio-and chemotherapy. A recent study by Foster (Foster et al., 1999) has shown that compounds that stabilize the DNA-binding domain of p53 in the active conformation not only promote the stability of the protein but also allow mutant p53 to maintain an active conformation.
) is a well-characterized radio-and chemoprotector which is clinically used to reduce the side eects of several cancer therapeutic protocols (Capizzi, 1999a,b,c) . In vivo, WR2721 is converted to the active, dephosphorylated form, WR1065, by alkaline phosphatase. WR1065 is a potent radical scavenger and there is convincing evidence that it reduces DNA-damage caused by reactive oxygen species (Marzatico et al., 2000) . The exact molecular mechanism of selective cytoprotection of normal cells is however unknown. It has been proposed that normal tissues, due to their higher alkaline phosphatase content, can more eciently transform WR2721 to its active metabolite than the majority of tumor cells, which have low alkaline phosphatase levels (Calabro-Jones et al., 1985) . At cellular pH, WR1065 exists in a cationic form similar to putrescine and shows the same 1,3-diaminopropano moiety as spermidine and spermine. Putrescine, spermidine and spermine are ubiquitous polyamines that play essential roles in normal cell phsysiology and cell growth (Pegg, 1988) . Polyamines have been shown to protect cells from radiation-induced mutagenesis and death even when administered after exposure to radiation (Grdina et al., 1995; Shigematsu et al., 1994) . In addition, recent studies have suggested that alteration of polyamine metabolism may aect p53 protein accumulation and activity (Kramer et al., 1998 (Kramer et al., , 1999 .
We have previously shown that WR2721 induces the DNA-binding activity of wild-type p53 in a dosedependent manner, which could contribute to its protective eects (North et al., 2000) . In the present study, we have used the yeast functional assay, originally described by Flaman et al. (1995) to examine the eects of WR2721 on the transcriptional activity of the p53 protein. In this assay, yeast generate normal size, white colonies when expressing a functional p53, and small red colonies when expressing a transcriptionally inactive (mutant) p53. Using the temperaturesensitive p53 mutant V272M (valine to methionine at codon 272), we have de®ned conditions in which yeast colonies show an intermediate phenotype (pink colonies) and we have studied whether the addition of WR2721 modulates p53 transcriptional activity and consequently restores the wild-type phenotype. In addition, we studied a series of 15 mutants which dier in their transcriptional activity towards dierent p53-responsive promoters. Since WR2721 has a polyamine-like structure, the eects of other natural polyamines, including spermidine, spermine and putrescine were also studied.
Results

Temperature-sensitivity of the V272M mutant p53
The p53 mutant V272M was initially characterized in the esophageal cancer cell line TE1 (Barnas et al., 1997) . In this cell line, the mutant p53 was shown to have a temperature-sensitive phenotype, with wild-type p53 properties in cells grown at 328C and mutant properties in cells grown at 378C. The same mutant has been found by others to show temperature-sensitivity for conformation when expressed in vitro (Rolley et al., 1995) , as well as in a yeast functional assay (Jia et al., 1997) .
The results described in this section were obtained using the yeast strain yIG397 (Flaman et al., 1995) , in which expression of the ADE2 gene is driven by the p53-binding sequence RGC (Ribosomal Gene Cluster). Figure 1 shows the mutants V272M and R248W grown at dierent temperature using the yeast assay. On limiting adenine plates, at 308C, colonies expressing V272M were almost exclusively white (corresponding to the wild-type p53 phenotype). Culture at 358C resulted in yeast colonies adopting a red color (mutant phenotype), whereas most of the yeast colonies were pink when grown at 338C. In parallel, we tested R248W, a well characterized Class I mutant, which is highly prevalent in many human cancers. Colonies expressing this mutant were red at all three temperatures. These results indicate that V272M at 338C adopts an intermediate phenotype that partially retains transcriptional activity.
The RGC sequence corresponds to a high-anity p53-binding site but does not occur as such in the regulatory regions of any gene that is physiologically regulated by p53 (Kern et al., 1991) . To con®rm the temperature-sensitivity of V272M with biologicallyrelevant p53 target sequences, we used three dierent yeast strains containing p53-binding sites derived from the p21/WAF1, BAX or PIG3 promoters controlling the p53-dependent expression of the same (ADE2) reporter gene (Flaman et al., 1998; Robert et al., 2000) .
The mutant V272M exhibits temperature-sensitivity in all four strains used (white colonies at 308C and red colonies at 358C). At 338C, however, we noticed important dierences between the yeast strains ( Figure  2 ). Whereas YPH-p21 grew as white colonies, YPH-PIG3 was pink and YPH-bax was red. These dierences re¯ect the variable anity of V272M for dierent p53-binding DNA sequences, and are consistent with the results of Flaman et al. (1998) who also observed that wild-type p53 had a lower anity for the BAX site than for the p21 site. Under the conditions used here, the PIG3 site appears to show an intermediate p53-binding capacity between those of p21 and BAX and comparable to the RGC sequence. However, the fact that YPH-PIG3 shows a dierent growth rate than the three other strains precludes precise comparison of the anity of V272M for PIG3 and for other binding sites.
Effects of WR2721 on the transcriptional activity of V272M
We have previously demonstrated that Amifostine (WR2721) induces the accumulation and activation of wild-type p53 protein in mammalian cells. This activation is followed by the induction of p53 target genes and has an eect on cell cycle progression (North et al., 2000) . These data raise the possibility that modulation of p53-dependent pathways plays a role in the protective action of WR2721.
Having shown, in the yeast assay, that the V272M mutant is subject to regulation by small changes in temperature, we took advantage of the¯exibility of this mutant to determine whether addition of WR2721 and other exogenous polyamines to the yeast culture medium might aect the activity of the mutant p53 protein. Figure 3 shows that the addition of WR2721 induced yIG397-RGC colonies to switch from pink to white color when cultured at 338C. No eect of the drug was observed on the color of yeast expressing the nonexible mutant p53 R248W, which was consistently red in the presence of WR2721 (data not shown).
Quantitative analysis of the color changes showed that the switch from pink to white was detectable with as little as 2 mM WR2721 ( Figure 3b ). The eect of WR2721 increased in a dose-dependent manner up to 8 mM, at which concentration the colonies grown at 338C were indistinguishable from those cultured at 308C, re¯ecting the wild-type phenotype of the protein.
To better understand the eect of WR2721 on p53 V272M, we tested its ability to modulate the transactivation of other p53-dependent reporters in yeast. Using YPH-PIG3 strain, the eects were very similar to those seen with the yIG397-RGC strain. However, in YPHbax, the colonies grew red in the absence of the drug and switched to pink upon addition of 8 mM WR2721. On the other hand, YPH-p21 constantly grew as white colonies at 338C, irrespective of the presence of WR2721. These results con®rm the dierent anity of p53 for the various promoters, as reported above.
In order to determine if the eect of WR2721 on the V272M mutant p53 was due to increased amounts of p53 protein, we performed a Western blot analysis. No signi®cant increase in p53 protein level was seen in yeast grown in selective medium with dierent doses of WR2721 (Figure 4) , showing that this drug does not enhance production of p53 protein, but more likely acts by stabilizing the wild-type conformation of preexisting protein. However, it should be noted that exposure to amifostine results in the production of a band of lower molecular weight, which may correspond to a form of p53 carrying speci®c posttranslational modi®cations. Yeast containing the ADE2 gene under the p53-dependent promoter sequence RGC (strain yIG397) were used to express p53 cDNA with the appropriate mutation, as speci®ed in Material and methods, and were incubated at 308C, 338C or 358C for 3 days. Wild-type (WT) and mutant (MUT: R248W) were used as controls. An average of 250 colonies were grown for each condition. (b) Quantitative evaluation of p53 transcriptional activity in yIG397-RGC. Pictures as shown in (a) were analysed using image analysis software (as described in Material and methods). The degree of color was expressed as relative units. Each histogram represents an average+standard deviation for 30 randomly selected colonies. The dierences between R248W and V272M, and between V272M and wild-type protein, of the relative units were statistically signi®cative (P40.001) Figure 2 Eects of temperature on transcriptional activity of V272M mutant towards four distinct, p53-dependent promoters. Temperature-sensitivity of V272M in yeast strains carrying dierent p53-binding sequences. The V272M mutant was expressed in the following yeast strains: yIG397 (RGC sequence), YPH-p21 (p21 derived sequence), YPH-bax (BAX-derived sequence) and YPH-PIG3 (PIG3-derived sequence). The yeast were incubated at 308C, 338C or 358C for 3 days Oncogene Rescue of mutated p53 activity by amifostine (WR2721) D Maurici et al
WR2721 modulates the transcriptional activity of various p53 mutants
We next tested whether the eect observed with V272M was an exclusive characteristic of this mutant or was a more general phenomenon shared with other p53 mutants. For this purpose, we analysed the eect of WR2721 on 15 mutants with dierent structural characteristics and at four temperatures (248C, 308C, 338C and 358C) with four dierent p53-responsive promoters. Dierences in the yeast color phenotype were observed only at 338C. Table 1 shows the eect of WR2721 at 338C on all the mutants tested.
The results suggest that there are two dierent categories of mutants: group I, or non responders, (G117E, K120R, R175P, P177S, R248W, D259V, G279E, G279R, G279V) which maintained their red phenotype even after the addition of WR2721 and at all temperatures tested; group II, or responders (E180K, P219V, D228V, P250L, D259N, R283H) with which WR2721 exerted an eect on the transcriptional activity of p53 towards BAX, PIG3 and RGC promoters. With yIG397-RGC, all the responder mutants converted their phenotype from red to pink or from pink to white in the presence of WR2721. When tested on PIG3 and BAX promoters, a positive eect was seen in three out of six responder mutants (Table 1 ). In particular, P250L was the least exible mutant since it responded to WR2721 when tested with the RGC promoter only. It is interesting to note that responder mutants except P250L showed a pink phenotype with p21 promoters at 338C. We conclude that WR2721 was able to convert the phenotype of a number of dierent p53 mutants to wild-type, re-establishing the transcriptional activity of the protein presumably by restoring the wild-type conformation.
Effect of synthetic exogenous polyamines
The chemical properties of WR2721 suggest at least two possible mechanisms to explain its eect on p53. First, the active dephosphorylated form of the drug is a free thiol, and p53 has been shown to be intrinsically very sensitive to thiol oxidation-reduction both in vitro and in intact cells (Hainaut and Milner, 1993; Rainwater et al., 1995; Verhaegh et al., 1997) . Second, the polyamine moiety of the drug may interfere with the p53 folding pathway. Recent evidence suggests that disruption of polyamine metabolism can activate p53 by a mechanism which is still poorly understood (Kramer et al., 1998 (Kramer et al., , 1999 Li et al., 1999) . To test the second hypothesis, we examined the eects of natural polyamines such as putrescine, spermidine and spermine, on p53 transcriptional activity of the V272M and R283H mutants in the yIG397-RGC and YPH-PIG3 yeast strains.
The addition of putrescine to the V272M and R283H mutants converted the yeast colonies from pink to white in a dose-dependent manner, reestablishing the wild-type phenotype and transcriptional activity of mutant p53. The eect of putrescine on p53 V272M is shown in Figure 5 . The eects of spermine and spermidine were dicult to evaluate because of their toxicity. These polyamines drastically modi®ed the growth rate of yeast colonies when used at concentrations higher than 1 mM. However, at 500 mM, partial restoration of the white phenotype was detected with spermine, but not with spermidine (data not shown). These results suggest that the polyamine moiety of WR2721 plays a crucial role in its capacity to modulate p53 activity in this yeast-based assay. 
Discussion
In this study, we have shown that WR2721, a radioand chemoprotector already shown to be a potent activator of p53 in cell lines expressing wild-type p53, is able to restore completely or partially the wild-type phenotype and consequently the transcriptional activity of speci®c p53 mutants in a yeast functional assay.
We initially used a temperature-sensitive mutant, V272M, to determine conditions in which yeast colonies adopt an intermediate phenotype (pink colonies) between wild-type (white colonies) and mutant (red colonies). We reasoned that, under these conditions, the protein was in a delicate balance between the wild-type and mutant conformations. Addition of WR2721 or exogenous polyamines to the culture medium led to the partial or total rescue of transcriptional activity in a dose-dependent manner. The extent of this transcriptional rescue varied according to the sequence of the p53-responsive promoter used, with complete rescue (pink to white) with RGC and PIG3 promoters, and partial rescue with BAX promoter, while p21 promoter was constitutively active under the condition of our assay. These dierences are in agreement with published observations on the relative anities for various p53-dependent promoters.
Several other mutants, in addition to V272M, showed increased transcriptional activity in the presence of WR2721. These mutants, classi®ed as WR2721 responders, include E180K, P219L, D228V, P250L, D259N and R283H. All these mutants are, to some extent, temperature-sensitive. In the case of D228V and R283H, we observed an inverse pattern of temperaturesensitivity, with white (wild-type) phenotype at 358C and a red (mutant) phenotype at 308C (data not shown). We also identi®ed a group of non responders, which includes G117E, K120R, R175P, P177S, R248W, D259V, G279E, G279R and G279V.
Closer examination of the position of the mutation in the tertiary structure of p53 in both WR2721 responders and non responders, revealed several interesting features (Figure 6 ). First, both groups of mutations fall within the¯exible loops on both sides of the protein (DNA binding surface and external Figure 5 Eect of putrescine on the transcriptional activity of V272M. yIG397-RGC transformed with V272M were cultured at 338C with or without putrescine at 4, 8 or 12 mM. Images of representative colonies were analysed using image analysis software as described in the legend of Figure 1b . The pLS76 vector (containing wild-type p53) was used as positive control Localization of the mutation in secondary structure motifs of p53 (Cho et al., 1994) . S: beta strand; H: Helix; L: Loop.
b
Indicates mutants never found in human tumors of cell lines (IARC database, data R4, http://www.iarc.fr/p53/index.html). TP53 mutants were expressed in dierent yeast strains, with the ADE2 reporter gene under the control of p53 responsive elements derived from p21 (YPH-p21), BAX (YPHbax), PIG3 (YPH-PIG3) promoters, or under the control of the RGC (yIG397) sequence. Transformed yeast were plated in presence (+) or in the absence (7) of 8 mM WR2721. After 3 days at 338C, the color of the colonies was scored: +, white; +/7, pink; 7, red. Underlined are the results showing a color dierence in the presence of WR2721
Oncogene Rescue of mutated p53 activity by amifostine (WR2721) D Maurici et al surface), leaving intact the beta-sheet scaold. Second, mutations of the non responders group are often at codons in direct contact with DNA (#248, #120) or at codons playing essential, structural roles in the maintenance of the protein-DNA contacts (#175). In contrast, mutations of the responders group are at residues which neither directly bind to DNA nor play crucial roles in the overall architecture of the DNAbinding surface. These observations suggest that the mutations of the responders group are somehow milder than those of the non responders group, so that the responders retain an intrinsic capacity to fold into thè wild-type' conformation. An interesting case is mutation at codon 259, which falls into both categories, depending on the substitution (D259V: non responders; D259N responders). The aspartate (D) to asparagine (N) substitution is more conservative in terms of structure than the aspartate (D) to valine (V) substitution, indicating that response to WR2721 is associated with mutations having limited structural consequences.
The mechanisms by which WR2721 modulates p53 protein activity are not known. Our results show that the increase in transcriptional activity in yeast is not due to protein accumulation in response to WR2721.
In a recent study (North et al., 2000) we showed that WR2721 and its active metabolite WR1065 (dephosphorylated form), stimulate wild-type p53 protein activity in intact cells. The structural resemblance of the active form WR1065 to polyamines has long been noted. However, whether the modulatory eect of WR2721 is due to the polyamine-like moiety or to the reactive, free thiol group, or to both, is not clearly understood.
In the present study, we have also shown that a naturally occurring polyamine, putrescine, had eects similar to those of WR2721 in the yeast functional assay. Two other polyamines, spermine and spermidine, also had some eect on p53 activity, but full modulation of the protein was prevented by their toxicity to the yeast. Thus, it would appear that the polyamine moiety of WR2721 plays an essential role in the modulation of p53 protein activity in the yeast. How polyamines exert this modulatory eect is a matter of speculation. Recent studies in mammalian cells have shown that perturbation of polyamine metabolism results in accumulation and activation of wild-type p53, followed by G 1 arrest. This eect was observed with two distinct experimental approaches, one involving the addition to the culture medium of synthetic polyamines that deplete the endogenous, natural polyamine level (Kramer et al., 1999) and the other involving the use of a chemical inhibitor of ornithine decarboxylase, the rate-limiting enzyme in polyamine biosynthesis (Li et al., 1999) . As suggested in these experiments with mammalian cells, perturbation of polyamine metabolism may activate a signaling pathway that modulates p53 functions. It is also possible that polyamines act on p53-DNA interactions in a more direct manner. Indeed, polyamines are heavily charged, cationic molecules that interact with both nucleic acids and proteins to stabilize macromolecular complexes. In particular, polyamines facilitate the oligomerization of nucleosomal arrays in vitro, and may stabilize the highly condensed state of chromosomal ®bers in vivo (Pollard et al., 1999) . Therefore, polyamines may act as stabilizers of p53-DNA interactions, leading to enhanced DNA-binding and transcriptional activity of mutants that retain the capacity to interact weakly with DNA. Finally, polyamines may directly interact with the p53 protein, and help to stabilize the active, wild-type conformation. In this respect, the similarity between the eect of polyamines and that of temperature on p53 temperature-sensitive mutants suggests that the interaction with polyamines may decrease the energy required for these mutants to fold into the`wild-type' conformation.
In conclusion, the results reported here indicate that the expression of selected p53 mutants in a yeast functional assay represents an interesting experimental approach to detect and analyse whether certain drugs can modulate or restore p53 transcriptional activities. Further analysis of the eect reported here may help to elucidate how WR2721 and several other polyamines exert their eects on growth regulation and on radioand chemoprotection of cells. Figure 6 Three-dimensional structure of p53. This ®gure shows the positions of the residues mutated in the responders (top) and in the non responders group (bottom). The model was produced with the RASMOL 2.6 modeling software using a modi®ed version of the PDB ®le 1 TUP
Materials and methods
Yeast strains and media
The Saccharomyces cerevisiae haploid strains used were yIG397 [MATa ade2-1 leu2-3,112 trp1-1 his3-11,15 can1-100ura3-1 URA3 36RGC::pCYC1::ADE2] (Flaman et al., 1995) . YPH-p21 [MAT alpha ura3-52 lys2-801 ade2-101 trp1-D63 his3-D200 leu2-D1 URA3 p21::pCYC1::ADE2] (Flaman et al., 1998) (p21 reporter contains a 20mer sequence found 2.4 kb upstream of the p21 promoter: 5'GAACATGTCC-CAACA TGT TG-3') (el Deiry et al., 1993) . YPH-bax [MAT alpha ura3-52 lys2-801 ade2-101 trp1-D63 his3-D200 leu2-D1 URA3 bax::pCYC1::ADE2] (Flaman et al., 1998) (BAX reporter contains a 39mer sequence found 486 ± 448 bp upstream of the BAX promoter: 5'-TCACAAGTTAGAGA-CAAGCCTGGGCGTGGGCTATATTG-3') (Miyashita and Reed, 1995) , YPH-PIG3 [MAT alpha ura3-52 lys2-801 ade2-101 trp1-D63 his3-D200 leu2-D1 URA3 Pig3::pCYC1::ADE2] (Robert et al., 2000) (PIG3 reporter contains a 20mer sequence found 328 ± 308 bp upstream of PIG3 promoter: 5'CAGCTT-GCCCACCCATGCTC-3') (Polyak et al., 1997) . These strains contain the ADE2 reporter gene under the p53 responsive element described above. They were transformed with an appropriate yeast expression vector harboring human wildtype or mutant p53 cDNA under an ADH1 promoter. The expression of wild-type p53 conferred adenine prototrophy resulting in white, normal size colonies, while the expression of a mutant p53 unable to transactivate the ADE2 gene conferred adenine auxotrophy and the growth of small red colonies.
Vectors containing wild-type or mutant p53 cDNA
The pLS76 yeast expressing vector (CEN6/ARS4, LEU2) containing wild-type p53 (Ishioka et al., 1993) or pRDI-22 containing mutant p53 cDNA (Flaman et al., 1995) , was used to transform the yeast strains described above. All the mutants analysed, except V272M, were available from previous studies: K120R, R175P, R283H (Flaman et al., 1998) . P219L, D228V, G117E, G279E, D259N (Inga et al., 1997) , D259V (Inga et al., 1998) , P177S, E180K, P250L, G279V , G279R (Kelly et al., 1999) .
The vector containing the temperature-sensitive V272M p53 was prepared using cDNA isolated from the TE1 esophageal cancer cell line (Barnas et al., 1997) . The cells were cultured in RPMI 1640 supplemented with 10% FCS and penicillin/ streptomycin/glutamine in 10% CO 2 . mRNA was puri®ed with Quickprep micro mRNA kit (Pharmacia) and eluted in 200 ml of water. cDNA was synthesized at 428C for 45 min by 100 units of Superscript II (GIBCO ± BRL) from 10 ml of mRNA in 25 ml buer (GIBCO ± BRL) containing 0.4 mg of oligo-dT15 (Promega). PCR was performed with primers P3 [5'-ATTT GATGCTG TCCCCGGA CGATA TTGAA(s)C -3' ] and P4 [5'-ACCCTTTTTGGACTTCAGGTGGCTGGA-GT(s)G-3' where (s) represents a phosphorothioate linkage] for 35 cycles at 948C for 30 s, 658C for 60 s and 728C for 80 s. Five ml of the cDNA reaction product were ampli®ed in 25 ml of Pfu buer (Stratagene) plus 1.25 units of Pfu DNA polymerase (Stratagene), 100 ng of primers, 10% (vol/vol) DMSO, and 50 mM dNTPs. The PCR product was cloned in pRDI-22-expressing vector and the presence of the V272M mutation was con®rmed by sequencing.
Yeast functional assay
The yeast functional assay was performed as described by Flaman et al., (1995) , using yeast plated on synthetic dropout minimal medium (Difco, Milano, Italy) minus leucine plus adenine (5 mg/ml) and incubated for 3 days at either 248C, 308C, 338C or 358C in a humidi®ed atmosphere.
Treatment with WR2721 and other polyamines WR2721 (provided by US Bioscience), dissolved in water and ushed with argon to avoid oxidation, was spread on the agar plates 30 min before seeding the yeast. Clones expressing dierent p53 mutants in the yeast strains yIG397-RGC, YPH-bax, YPH-p21 and YPH-PIG3 were streaked on agar plates containing none, 2, 4, 6 or 8 mM WR2721 along with a negative control (the same strain expressing wild-type p53) and a positive control (p53 V272M). Plates were then incubated at four temperatures (248C, 308C, 338C, or 358C). Mutants were classi®ed as responders to WR2721 when a color shift (red to pink; pink to white) was apparent in clones on plates with WR2721 versus plates without WR2721, and non-responders if such a shift was absent.
Putrescine, spermidine and spermine (all from Sigma) were dissolved in water and¯ushed with argon to avoid oxidation. Putrescine was used at the same concentration as WR2721, whereas spermine and spermidine were used at 50, 125, 250 and 500 mM. The three polyamines were tested only with V272M and R283H p53 mutants in yIG397-RGC and YPH-PIG3 strains.
Image analysis
The color intensity of the yeast colonies was evaluated in a semi-quantitative manner, using the image analysis software Aphelion 2.3 (ADCIS, Caen, France). Brie¯y, the culture dishes were scanned using a Nikon Scantouch scanner. Color images were decomposed into three sets of black and white pictures (corresponding to red, green and blue channels). Using the pictures generated in the red channel, the pixel value range of individual colonies was recorded and expressed on a scale of relative units from 0 (black) to 255 (white). On this scale, red colonies scored an average of 119.8+11.2 and white colonies scored 231.5+11.8. For each measurement, at least 30 randomly selected colonies were analysed. Results were statistically analysed using a standard T test.
Yeast protein extracts and Western immunoblot analysis
Yeast extracts were prepared as described (Di Como and Prives, 1998) with minor modi®cations. Brie¯y, the extracts were made from two OD 600 units of cell suspension. After centrifugation, pellets were washed with cold water, and then resuspended in 250 ml of extraction buer (Tris pH 7.4 50 mM, NaCl 250 mM, SDS 0.1% DTT 2 mM, NP40 0.5%), in the presence of a mixture of protease inhibitors: 0.5 mg/ml leupeptin, 0.5 mM phenylmethylsulfonyl¯uoride, 2 mg/ml aprotin, 0.7 mg/ml pepstatin A (all from Sigma). The yeast were lysed by vortexing for 15 min at 48C in the presence of glass beads (Sigma G-18772). The extracts were then centrifuged to eliminate the beads, the supernatant was recovered, recentrifuged 10 min at 13 000 g to eliminate cell debris and then stored at 7808C. Protein concentrations were determined using the Lowry method.
For detection by Western blot, 50 mg of yeast protein extracts were mixed with Laemmli buer, resolved on a 10% SDS-polyacrylamide gel, and transferred to PVDF membranes (Roche). Western blot analysis was performed with an enhanced chemiluminescence detection system (ECL, Amersham, UK) in accordance with the manufacturer's instruc-
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Rescue of mutated p53 activity by amifostine (WR2721) D Maurici et al tions. For p53 detection, the ®rst antibody used was DO7 (DAKO, Denmark) at 250 ng/ml; peroxidase-conjugated goat anti-mouse (Pierce) at the concentration of 250 ng/ml was used as secondary antibody.
